TPP Negotiators Reached Agreement With Sticky Compromise On Biologics Drugs
A big sticking point in the negotiations over the Trans-Pacific Partnership involved biologics medicines and vaccines created from living organisms. The dispute centered on patent protection: how many years drug companies should have before facing competition from generics. The negotiators ended up with a complicated compromise that gives drug makers five to eight years of protection. But nobody is really happy with the outcome.
Read more on NPR
No comments:
Post a Comment